OpSens Inc. has announced that it has received 510(k) regulatory clearance from the U.S. Food & Drug Administration (FDA) for the SavvyWire, its new guidewire for transcatheter aortic valve replacement (TAVR) procedures.
October 06, 2022
OpSens Announces FDA Clearance for the SavvyWire for Use in Transcatheter Aortic Valve Replacement (TAVR) Procedures
October 6, 2022 – OpSens Inc., a Quebec-based medical device cardiology-focused company, has announced that it has…
Read More
Results presented at the Heart Failure Society of America Annual Scientific Meeting
October 06, 2022
Cleveland Clinic-Led Trial Finds That Increasing Salt Intake Does Not Affect Patients Hospitalized with Congestive Heart Failure During Treatment
October 6, 2022 —  Findings from a Cleveland Clinic-led trial show that increasing the salt intake by mouth for…
Read More
The American Society of Echocardiography (ASE) is targeting its research funding over the next five years to help solve some of the mysteries around the early detection of a common form of heart failure.
October 05, 2022
American Society of Echocardiography Invests in Joint Research Initiative to Help Patients Suffering from Wide-Reaching Form of Heart Failure
October 5, 2022 —  The American Society of Echocardiography (ASE) is targeting its research funding over the next five…
Read More
CinCor Pharma, Inc. (NASDAQ: CINC) today announced that the company will present Phase 2 data from its BrigHtn trial evaluating baxdrostat in patients with treatment-resistant hypertension as part of the late-breaking science session
October 05, 2022
CinCor Pharma Announces Late-Breaking Presentation of Phase 2 BrigHtn Data for Baxdrostat in Treatment-Resistant Hypertension at the Upcoming 2022 American Heart Association Scientific Sessions
October 5, 2022 —  CinCor Pharma, Inc. (NASDAQ: CINC) today announced that the company will present Phase 2 data from…
Read More
Dr. Rakesh Arora to lead cardiac intensive care units and cardiac surgery research
October 05, 2022
UH Harrington Heart & Vascular Institute Recruits Renowned Cardiac Surgeon from Canada
October 5, 2022 —  University Hospitals (UH) Harrington Heart & Vascular Institute has a rich history of providing…
Read More
During the Heart Failure Society of America (HFSA) 2022 Scientific Meeting, Daxor Corporation announced new data from multiple studies validating the benefits of the company’s BVA-100 blood test for patients with heart failure.
October 05, 2022
Blood Volume Measurement Supports Heart Failure Patients, Studies Show
October 5, 2022 — New data presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2022,…
Read More
New analysis adds to growing body of evidence in support of the use of sotagliflozin, an investigational dual SGLT1 and SGLT2 inhibitor, in the treatment of heart failure
October 04, 2022
New Data Shows Heart Failure Treatment Guided by Daxor’s BVA-100 Lowers Hospital Length of Stay by 55%
October 4, 2022 — Newswise — Daxor Corporation, a global leader in blood volume measurement technology, today announces…
Read More
New analysis adds to growing body of evidence in support of the use of sotagliflozin, an investigational dual SGLT1 and SGLT2 inhibitor, in the treatment of heart failure
October 04, 2022
New Analysis of Soloist-WHF Trial Underscores Sotagliflozin’s Effect on Reducing Recurrent Heart Failure Events
October 4, 2022 — Lexicon Pharmaceuticals, Inc. announced that a new analysis of results from the SOLOIST-WHF Phase…
Read More
12 month data from The PRECISE Trial, the first global, prospective, randomized trial comparing diagnosis and evaluation pathways for stable chest pain, will be presented at the AHA 2022 Scientific Sessions.
October 04, 2022
HeartFlow Announces Late Breakers Presentation at the 2022 American Heart Association (AHA) Scientific Sessions
October 4, 2022 — HeartFlow, Inc., the leader in revolutionizing precision heart care, announced that the results of…
Read More
The stage is set for the American Heart Association (AHA) Scientific Sessions 2022, to be held November 5-7 at McCormick Place in Chicago, and virtually.
October 04, 2022
AHA Scientific Sessions 2022 Program, Late-breakers Announced
October 4, 2022 — The American Heart Association (AHA) Scientific Sessions 2022 is set for November 5-7 at McCormick…
Read More
By Christine Book
October 03, 2022
Cardiovascular Research Foundation’s (CRF) TCT 2022 in Review
The 34th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular…
Read More
The Impella CP with SmartAssist heart pump is a minimally invasive, temporary heart pump that uses real-time intelligence associated with improved survival and heart recovery. (Graphic: Business Wire)
By Melinda Taschetta-Millane
October 03, 2022
Top 10: Most-read Content in September
Here is a recap of what DAIC viewers found most interesting during the month of September: 1. Unloading with Impella…
Read More
Presentations highlight the significant potential clinical benefits of managing congestion in patients with heart failure with FUROSCIX (furosemide injection) at home
October 03, 2022
scPharmaceuticals Announces Data Presentations at the Heart Failure Society of America 2022 Annual Scientific Meeting
October 3, 2022 — scPharmaceuticals Inc., a pharmaceutical company focused on developing and commercializing products…
Read More
The first-of-its-kind patch, designed to offer comfort and free movement, provides actionable reports in under 24 hours to revolutionize the detection of conditions that cost the United States $363bn annually, allowing medical institutions to save more lives and scale their practice
October 03, 2022
Mawi launches Mawi Heart Patch
October 3, 2022 — Mawi, creators of AI-powered wearable medical devices for cardiac disease diagnostic and monitoring,…
Read More
The new ECHO lab enables cardiac teams to use ultrasound (or echocardiography) to assess the size and efficiency of heart chambers. Stress tests, coronary CTAs, and cardiac MRIs are also interpreted there.
October 03, 2022
Memorial Cardiac and Vascular Institute Battling Heart Disease in a New Place
October 3, 2022 — A new ‘ECHO lab’ at Memorial Hospital West is benefiting patients that may have heart disease and the…
Read More
September 29, 2022
HeartBeam Granted Patent for Signal Transformation from Vector Electrocardiogram (VECG) to 12-Lead Electrocardiogram (ECG)
September 29, 2022 —  HeartBeam, Inc., a cardiac technology company that has developed the first and only 3D-vector ECG…
Read More
Researchers at Mayo Clinic used artificial intelligence (AI) to evaluate patients’ electrocardiograms (ECGs) in a targeted strategy to screen for atrial fibrillation, a common heart rhythm disorder
September 29, 2022
AI-guided Screening Uses ECG Data to Detect a Hidden Risk Factor for Stroke
September 29, 2022 — Researchers at Mayo Clinic used artificial intelligence (AI) to evaluate patients’ …
Read More
Higher blood levels of collagen-derived molecule predict worse outcomes
September 29, 2022
Penn Study Identifies New Prognostic Biomarker for Heart Failure
September 29, 2022 — Bloodstream levels of a protein fragment called endotrophin can be used to predict outcomes in…
Read More
The multi-center first-in-men study evaluates the safety and performance of the next generation of BIOTRONIK’s Resorbable Magnesium Scaffold (RMS)
September 28, 2022
BIOMAG-I Clinical Trial Reaches Primary Endpoint at Six Month for Unique Next Generation Resorbable Magnesium Scaffold
September 28, 2022 —  In the "TCT Innovation" session Prof. Michael Haude, BIOMAG-I Coordinating Clinical Investigator…
Read More
Yeonsik Now, UMass Amherst assistant professor who holds a joint appointment in the Elaine Marieb College of Nursing and the College of Engineering’s electrical and computer engineering department, was awarded a projected four-year, $2.3 million grant from the National Institutes of Health’s National Heart, Blood and Lung Institute. Image courtesy of UMass Amherst
September 28, 2022
Wearing a Vest With Wireless Hardware for Five Minutes a Day May Help People With Heart Failure Stay Out of the Hospital
September 28, 2022 —  A University of Massachusetts Amherst nurse engineer is leading a team of researchers who are…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now